Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research reveals effectiveness of seizure treatments for children with autism

03.06.2011
Physicians will have a better guide for more effectively managing treatment of children experiencing seizures related to autism with the results of a study by researchers at Arizona State University and the University of Texas-Houston.

From 25 to 35 percent of people with autism will eventually experience full-scale seizures. Many others will have seizure-like brain activity, in which there is no obvious effect on muscles but potential effects on brain functioning, such as temporary loss of attention.

Little has been known about which traditional treatments for epileptic seizures and commonly used non-traditional alternative treatments are most effective for treating seizures or epilepsy specifically in children and adults with autism.

The new study provides insight into which treatments are most beneficial in such cases, says James Adams, a professor in the School for Engineering of Matter, Transport and Energy, one the ASU's Ira A. Fulton Schools of Engineering.

Adams conducted the research with Richard E. Frye, a physician specializing in child and behavioral neurology in the Department of Pediatrics at UT-Houston.

The complete study is published in the medical journal BMC Pediatrics, and is available online at http://www.biomedcentral.com/1471-2431/11/37/abstract

Adams says the study "suggests that several non-traditional treatments, such as special diets – ketogenic, Atkins, and gluten-free, casein-free diets, in particular – are worth further investigation as supportive treatments" for managing the health of people with autism who suffer from seizures.

Adams and Frye surveyed 733 parents whose children with autism experience seizures, epilepsy and/or seizure-like brain activity. They asked parents to rate the effectiveness of 25 traditional and 20 non-traditional medical treatments for seizures.

The survey also assessed the effects –and side-effects – of those treatments. Overall, antiepileptic drugs were reported by parents to reduce the occurrence and severity of seizures but worsened problems with sleep, communication, behavior, attention and mood.

Non-antiepileptic drugs were perceived to improve other symptoms but did not reduce occurrence of seizures or make them less severe to the same extent as the anti-epileptic drugs.

Four anti-epileptic drugs – valproic acid, lamotrigine, levetiracetam and ethosuximide – were reported to most often reduce the number or lessen the severity of seizures, and on average have little positive or negative effect on other symptoms of autism.

Certain traditional non-anti-epileptic drug treatments, particularly the ketogenic diet, were perceived to both lessen the number and reduce the severity of seizures and other symptoms.

SOURCES:
James Adams, jim.adams@asu.edu
Professor, materials science and engineering
School for Engineering of Matter, Transport and Energy
Director, ASU Autism/Asperger's Research Program
(480)965-3316
Richard E. Frye, M.D., Ph.D.
Assistant Professor of Pediatrics and Neurology
Director, Medically-Based Autism Clinic
Director, Laboratory for the Biological Basis of Neurodevelopmental Disorders
Department of Pediatrics
Division of Child and Adolescent Neurology
And The Children's Learning Institute
Houston, Texas
(713) 500-3245
MEDIA CONTACT:
Joe Kullman, joe.kullman@asu.edu
(480) 965-8122 direct line
(480) 773-1364 mobile
Ira A. Fulton Schools of Engineering
Arizona State University
Tempe, Arizona USA

Joe Kullman | EurekAlert!
Further information:
http://www.asu.edu

More articles from Health and Medicine:

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

nachricht Chronic stress induces fatal organ dysfunctions via a new neural circuit
21.08.2017 | Hokkaido University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Molecular volume control

22.08.2017 | Life Sciences

When fish swim in the holodeck

22.08.2017 | Life Sciences

Biochemical 'fingerprints' reveal diabetes progression

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>